Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-27

FDA Approved: EFAVIRENZ — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' generic efavirenz under an original application, enabling its use in antiretroviral therapy for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

ORIG AP for EFAVIRENZ (EFAVIRENZ)